ArticleLung2021

Lessons from Pharmacovigilance: Pulmonary Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy.

Stephen W Reese et al.PubMed ↗Publisher ↗

No numbers read from the abstract.